Financials
- Market Capitalization 39.12 M
- Employee 12
- Founded 2001
- CEO Joel Latham
- Website www.incannex.com.au
- Headquarter Delaware, United States
- FIGI BBG01J0814Y2
- Industry 药品制造—专业与仿制药
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.17
市销率
-7.22
每股股息
49.5
股息收益率 %
—
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4181 | INCR Intercure Ltd. - ordinary shares | 5.42 USD | -1.63% | -7.19% | +489.13% | +232.52% | 59.27 M USD | ||
| 4235 | SCYX SCYNEXIS, Inc. - Common Stock | 5.22 USD | +0.97% | -7.61% | +6.53% | +528.92% | 51.94 M USD | ||
| 4363 | CPHI China Pharma Holdings, Inc. Common Stock | 0.85 USD | -3.41% | -11.46% | -25.44% | +28.57% | 36.57 M USD | ||
| 4408 | RMTI Rockwell Medical, Inc. - Common Stock | 8.07 USD | +0.25% | +1.77% | +11.46% | +338.59% | 32.53 M USD |